MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 558066 | Name: Camedon

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Camedon is an interferon inducer.

Chemical Structure

Camedon
Camedon
CAS#144696-36-6

Theoretical Analysis

MedKoo Cat#: 558066

Name: Camedon

CAS#: 144696-36-6

Chemical Formula:

Exact Mass:

Molecular Weight:

Elemental Analysis:

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
IUPAC/Chemical Name
N/A
InChi Key
FQMLTEAEJZVTAJ-UHFFFAOYSA-M
InChi Code
1S/C15H11NO3.Na/c17-14(18)9-16-12-7-3-1-5-10(12)15(19)11-6-2-4-8-13(11)16;/h1-8H,9H2,(H,17,18);/q;+1/p-1
SMILES Code
[Na+].c1cccc2n(c3ccccc3c(c12)=O)CC(=O)[O-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 0.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Barinskiĭ IF, Davydova AA, Gribencha SV, Lazarenko AA. [Effectiveness of the interferon inducers ridostin and camedon in prevention and treatment of experimental alpha- and flavivirus infections]. Vopr Virusol. 1996 May-Jun;41(3):133-5. Russian. PubMed PMID: 8928508. 2: Nosik NN, Nosik DN, Kuznetsova NV. [The inhibiting action of interferon inducers on the multiplication of the human immunodeficiency virus]. Vopr Virusol. 1992 Mar-Apr;37(2):92-4. Russian. PubMed PMID: 1441434. 3: Glushkov NI, Guliaev AV, Pavelets KV, Musukaev KhM, Chërnykh DA, Ioganson DR. [Improvement in the diagnosis, therapy, and prevention of complications in patients with rectal cancer]. Vopr Onkol. 2012;58(4):498-501. Russian. PubMed PMID: 23607204. 4: Glushkov NI, Shabashova NV, Frolova EV, Uchevatkina AE, Kubachev KG, Novakovskiĭ VV, Popkov VV. [The efficacy of Neovir in the combined treatment of patients with operable tumors of the gastrointestinal tract]. Vestn Khir Im I I Grek. 1999;158(2):59-61. Russian. PubMed PMID: 10368895. 5: Maksimov SL, Iushchuk ND, Roslyĭ IM, Kravchenko AV, Danilova TV. [Neovir therapy in acute hepatitis C]. Zh Mikrobiol Epidemiol Immunobiol. 2003 Jan-Feb;(1):64-7. Russian. PubMed PMID: 12630357. 6: Cheknev SB, Mezentseva MV, Narovlyansky AN, Kobyakina NA, Ershov FI. Correlations between in vitro effects of preparations of interferon and its inducers on blood cells in patients with multiple sclerosis. Bull Exp Biol Med. 2001 Apr;131(4):382-4. PubMed PMID: 11550032. 7: Tsyrlina EV, Bakhidze EV, Volkova AT, Kriukova OG, Chepik OF, Maksimov SIa, Bershteĭn LM. [Effect of neoadjuvant therapy with neovir on the level of steroid hormone receptors in endometrial cancer tissue]. Vopr Onkol. 2001;47(2):214-7. Russian. PubMed PMID: 11383460. 8: HARADA K, KAMEDA M, SUZUKI M, MITSUHASHI S. DRUG RESISTANCE OF ENTERIC BACTERIA. 3. ACQUISITION OF TRANSFERABILITY OF NONTRANSMISSIBLE R(TC) FACTOR IN COOPERATION WITH F FACTOR AND FORMATION OF FR(TC). J Bacteriol. 1964 Nov;88:1257-65. PubMed PMID: 14234779; PubMed Central PMCID: PMC277402. 9: Surkov KG, Tsyrlina EV, Konstantinova MM, Bersteĭn LM. [Neovir, an interferon inductor, modifies expression of steroid hormone receptors in hormone-dependent tissues and restores sensitivity to tamoxifen in patients with inoperable breast cancer]. Vopr Onkol. 1996;42(6):28-32. Russian. PubMed PMID: 9123898. 10: KUROMARU G. The field investigation of tuberculosis made in Kameda-machi, Akita prefecture. Kekkaku. 1952 Jan;27(1):11-5; English extract, 48. PubMed PMID: 14918302. 11: Maksimov SL, Iushchuk ND, Roslyĭ IM, Kravchenko AV, Danilova TV. [Effect of neovir in the treatment of acute hepatitis C]. Zh Mikrobiol Epidemiol Immunobiol. 2001 May-Jun;(3):84-7. Russian. PubMed PMID: 11550570. 12: Zemskov AM, Korotkikh NG, Nektarevskaia IB, Suvorova IM. [Efficiency of immune correction in patients with chronic traumatic mandibular osteomyelitis]. Stomatologiia (Mosk). 2001;80(6):31-4. Russian. PubMed PMID: 11881458. 13: HARADA K, KAMEDA M, SUZUKI M, MITSUHASHI S. DRUG RESISTANCE OF ENTERIC BACTERIA. II. TRANSDUCTION OF TRANSMISSIBLE DRUG-RESISTANCE (R) FACTORS WITH PHAGE EPSILON. J Bacteriol. 1963 Dec;86:1332-8. PubMed PMID: 14086110; PubMed Central PMCID: PMC283650. 14: Mikhaĭlov IG, Maksimov SIa, Novik VI, Safronnikova NR, Vishnevskiĭ AS, Prianishnikov VA, Lyshev AA. [A comparative evaluation of treatment methods for a genital papillomavirus infection in women with different viral genotypes]. Vopr Onkol. 2000;46(3):340-3. Russian. PubMed PMID: 10976283. 15: Delektorskiĭ VV, Malinovskaia VV, Strizhakov AN, Iashkova GN, Kagramanova ZhA, Genkin DD, Parfenov VV, Galiautdinov DSh, Balandin AN, Lebedeva TV. [The interferon inducer neovir (kamedon) in the combined treatment of chronic inflammatory diseases of the adnexa uteri of chlamydial etiology (a clinical electron-microscopic study)]. Antibiot Khimioter. 1995 May;40(5):42-7. Russian. PubMed PMID: 8534181.

View History

GSK481

GSK481

Featured